Premium
Anti‐VEGF for the treatment of serous and vascularized RPE detachment n exudative AMD
Author(s) -
KAPETANIOS A
Publication year - 2011
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.3112.x
Subject(s) - choroidal neovascularization , photodynamic therapy , medicine , ophthalmology , serous fluid , retinal pigment epithelium , retinal detachment , macular degeneration , neovascularization , vegf receptors , retinal , angiogenesis , pathology , chemistry , organic chemistry
Choroidal neovascularization (CNV) associated with retinal pigment epithelial detachment (PED) in AMD is a subtype of AMD with a bad prognosis and a high risk of retinal pigment epithelium (RPE) tear. The efficacy of current treatment options is limited, and the anatomical and functional results are not favourable after both laser photocoagulation and photodynamic therapy (PDT). We will discuss the effect and outcome of anti‐VEGF intravitreal injection in treating CNV associated with PED in AMD.